Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

ARWRARWR
5 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in ARROWHEAD PHARMACEUTICALS IN

BAKER BROS. ADVISORS LP holds 2M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $162.4M as of 2026-Q2. ARWR represents 0.8% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$162.4M

Current Shares

2M

Total Value Change

+$147.6M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2M
0.0%
$162.4M0.8%$81.51
0
2026-Q1
Decreased
2M
-8.4%
$124.9M0.7%$64.10
0
2025-Q4
Increased
2.2M
+30.2%
$144.4M0.8%$67.25
54
2025-Q3
Increased
1.7M
+77.9%
$57.6M0.4%$33.78
54
2025-Q2
New
939,174
-
$14.8M0.1%$16.08
47

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used